FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037128519> ?p ?o ?g. }

• W2037128519 endingPage "1061" @default.
• W2037128519 startingPage "1054" @default.
• W2037128519 abstract "To evaluate the effectiveness of budesonide inhalation suspension relative to other common asthma therapies in a high-risk population, a study was conducted to compare the risk of having a repeat asthma-related hospitalization or emergency department (ED) visit in a Medicaid population of children; the relationship between asthma medication adherence level and repeat asthma hospitalizations or ED visits was also evaluated.Children eight years of age or younger, with a hospitalization or ED visit for asthma between January 1999 and June 2001 (index event), were identified in a Florida Medicaid database. Claims data for each child were examined 12 months before and after the index event. Cox proportional hazards regression was used to model the risk of subsequent asthma exacerbation according to the asthma medication received during the first 30 days after the index event. Logistic regression was used to model the relationship between medication adherence as measured by the medication possession ratio (MPR) and the likelihood of a subsequent asthma exacerbation.There were 10,976 children in the study. Patients who had a claim for budesonide inhalation suspension had a lower risk of a subsequent hospitalization or ED visit (hazard ratio, 0.55; 95% confidence interval, 0.41-0.76; p < 0.001) than patients who did not have budesonide inhalation suspension claims. Other controller medications were not associated with a reduction in the risk of subsequent asthma exacerbations. Adherence to medication was poor (a median MPR of 0.08 for budesonide inhalation suspension and a median MPR of 0.16 for any asthma controller medication). The odds of a repeat hospitalization or ED visit were significantly lower for children who were adherent to their asthma controller medication.Children with asthma and insured by Medicaid were at a high risk of repeat exacerbations leading to increased hospitalizations and ED visits. Treatment with budesonide inhalation suspension in the first 30 days after a hospitalization or ED visit for asthma was associated with a significant reduction in the risk of repeat asthma-related hospitalizations or ED visits during the following year. Children who were adherent to their asthma controller medication had significantly lower odds of having a subsequent asthma exacerbation." @default.
• W2037128519 created "2016-06-24" @default.
• W2037128519 creator A5020302531 @default.
• W2037128519 creator A5031725087 @default.
• W2037128519 creator A5039570345 @default.
• W2037128519 creator A5058353960 @default.
• W2037128519 creator A5062152763 @default.
• W2037128519 date "2007-05-15" @default.
• W2037128519 modified "2023-09-25" @default.
• W2037128519 title "Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan" @default.
• W2037128519 cites W1505422261 @default.
• W2037128519 cites W1912226737 @default.
• W2037128519 cites W2003120837 @default.
• W2037128519 cites W2005579411 @default.
• W2037128519 cites W2024250569 @default.
• W2037128519 cites W2054145986 @default.
• W2037128519 cites W2057112394 @default.
• W2037128519 cites W2060744874 @default.
• W2037128519 cites W2062963865 @default.
• W2037128519 cites W2063315649 @default.
• W2037128519 cites W2067039330 @default.
• W2037128519 cites W2067938037 @default.
• W2037128519 cites W2072238470 @default.
• W2037128519 cites W2075324875 @default.
• W2037128519 cites W2078723886 @default.
• W2037128519 cites W2079677927 @default.
• W2037128519 cites W2089141255 @default.
• W2037128519 cites W2096881544 @default.
• W2037128519 cites W2107818738 @default.
• W2037128519 cites W2117061551 @default.
• W2037128519 cites W2134040761 @default.
• W2037128519 cites W2135467277 @default.
• W2037128519 cites W2137798691 @default.
• W2037128519 cites W2142912379 @default.
• W2037128519 cites W2149185440 @default.
• W2037128519 cites W2150211703 @default.
• W2037128519 cites W2152772926 @default.
• W2037128519 cites W2155441883 @default.
• W2037128519 cites W2166687419 @default.
• W2037128519 doi "https://doi.org/10.2146/ajhp060256" @default.
• W2037128519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17494905" @default.
• W2037128519 hasPublicationYear "2007" @default.
• W2037128519 type Work @default.
• W2037128519 sameAs 2037128519 @default.
• W2037128519 citedByCount "68" @default.
• W2037128519 countsByYear W20371285192012 @default.
• W2037128519 countsByYear W20371285192013 @default.
• W2037128519 countsByYear W20371285192014 @default.
• W2037128519 countsByYear W20371285192015 @default.
• W2037128519 countsByYear W20371285192016 @default.
• W2037128519 countsByYear W20371285192017 @default.
• W2037128519 countsByYear W20371285192018 @default.
• W2037128519 countsByYear W20371285192019 @default.
• W2037128519 countsByYear W20371285192020 @default.
• W2037128519 countsByYear W20371285192021 @default.
• W2037128519 countsByYear W20371285192022 @default.
• W2037128519 countsByYear W20371285192023 @default.
• W2037128519 crossrefType "journal-article" @default.
• W2037128519 hasAuthorship W2037128519A5020302531 @default.
• W2037128519 hasAuthorship W2037128519A5031725087 @default.
• W2037128519 hasAuthorship W2037128519A5039570345 @default.
• W2037128519 hasAuthorship W2037128519A5058353960 @default.
• W2037128519 hasAuthorship W2037128519A5062152763 @default.
• W2037128519 hasConcept C118552586 @default.
• W2037128519 hasConcept C126322002 @default.
• W2037128519 hasConcept C151956035 @default.
• W2037128519 hasConcept C156957248 @default.
• W2037128519 hasConcept C160735492 @default.
• W2037128519 hasConcept C162324750 @default.
• W2037128519 hasConcept C187212893 @default.
• W2037128519 hasConcept C207103383 @default.
• W2037128519 hasConcept C2776042228 @default.
• W2037128519 hasConcept C2776136866 @default.
• W2037128519 hasConcept C2776534028 @default.
• W2037128519 hasConcept C2776954882 @default.
• W2037128519 hasConcept C2777014857 @default.
• W2037128519 hasConcept C2780724011 @default.
• W2037128519 hasConcept C2908647359 @default.
• W2037128519 hasConcept C42219234 @default.
• W2037128519 hasConcept C44249647 @default.
• W2037128519 hasConcept C50522688 @default.
• W2037128519 hasConcept C71924100 @default.
• W2037128519 hasConcept C73269764 @default.
• W2037128519 hasConcept C99454951 @default.
• W2037128519 hasConceptScore W2037128519C118552586 @default.
• W2037128519 hasConceptScore W2037128519C126322002 @default.
• W2037128519 hasConceptScore W2037128519C151956035 @default.
• W2037128519 hasConceptScore W2037128519C156957248 @default.
• W2037128519 hasConceptScore W2037128519C160735492 @default.
• W2037128519 hasConceptScore W2037128519C162324750 @default.
• W2037128519 hasConceptScore W2037128519C187212893 @default.
• W2037128519 hasConceptScore W2037128519C207103383 @default.
• W2037128519 hasConceptScore W2037128519C2776042228 @default.
• W2037128519 hasConceptScore W2037128519C2776136866 @default.
• W2037128519 hasConceptScore W2037128519C2776534028 @default.
• W2037128519 hasConceptScore W2037128519C2776954882 @default.
• W2037128519 hasConceptScore W2037128519C2777014857 @default.
• W2037128519 hasConceptScore W2037128519C2780724011 @default.

• next